Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 321

1.

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J; EPI-SCAN Steering Committee.

Respir Res. 2010 May 25;11:63. doi: 10.1186/1465-9921-11-63.

2.

Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.

Attaran D, Lari SM, Towhidi M, Marallu HG, Ayatollahi H, Khajehdaluee M, Ghanei M, Basiri R.

Int J Chron Obstruct Pulmon Dis. 2010 Oct 5;5:335-40. doi: 10.2147/COPD.S12545.

3.

Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD.

Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J.

Respir Res. 2011 Jan 5;12:3. doi: 10.1186/1465-9921-12-3.

4.

The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.

Kolsum U, Roy K, Starkey C, Borrill Z, Truman N, Vestbo J, Singh D.

Int J Chron Obstruct Pulmon Dis. 2009;4:149-56. Epub 2009 Apr 15.

5.

Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.

Gatta D, Aliprandi G, Pini L, Zanardini A, Fredi M, Tantucci C.

Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1068-73.

PMID:
22013730
6.

Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.

Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.

Clin Sci (Lond). 2008 Oct;115(7):225-32. doi: 10.1042/CS20070382.

PMID:
18307413
7.

[Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].

Long H, Luo H, Chen P, Li Y.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1090-6. doi: 10.3969/j.issn.1672-7347.2011.11.010. Chinese.

8.

[Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].

Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.

Rev Med Chil. 2010 Aug;138(8):957-64. doi: /S0034-98872010000800003. Epub 2010 Nov 26. Spanish.

9.

A gender difference in circulating neutrophils in malnourished patients with COPD.

Larsson S, Nordenson A, Glader P, Yoshihara S, Lindén A, Slinde F.

Int J Chron Obstruct Pulmon Dis. 2011;6:83-8. doi: 10.2147/COPD.S15351. Epub 2011 Jan 17.

10.

Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.

Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H.

Lung. 2008 Nov-Dec;186(6):403-9. doi: 10.1007/s00408-008-9106-6. Epub 2008 Sep 20.

PMID:
18807087
11.

The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.

Karadag F, Kirdar S, Karul AB, Ceylan E.

Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.

PMID:
18249305
12.

Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.

Izquierdo JL, Martínez A, Guzmán E, de Lucas P, Rodríguez JM.

Int J Chron Obstruct Pulmon Dis. 2010 Nov 8;5:387-94.

13.

Correlation between serum biomarkers and BODE index in patients with stable COPD.

Liu SF, Chin CH, Wang CC, Lin MC.

Respirology. 2009 Sep;14(7):999-1004. doi: 10.1111/j.1440-1843.2009.01608.x.

PMID:
19740260
14.

Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.

de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF.

Int J Chron Obstruct Pulmon Dis. 2014 Jul 29;9:735-43. doi: 10.2147/COPD.S64135. eCollection 2014.

15.

Associations between BODE index and systemic inflammatory biomarkers in COPD.

Gaki E, Kontogianni K, Papaioannou AI, Bakakos P, Gourgoulianis KI, Kostikas K, Alchanatis M, Papiris S, Loukides S.

COPD. 2011 Dec;8(6):408-13. doi: 10.3109/15412555.2011.619599.

PMID:
22149400
16.

Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study.

Boutou AK, Pitsiou GG, Stanopoulos I, Kontakiotis T, Kyriazis G, Argyropoulou P.

QJM. 2012 Jul;105(7):657-63. doi: 10.1093/qjmed/hcs024. Epub 2012 Feb 21.

PMID:
22355163
17.

Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease.

van den Borst B, Gosker HR, Wesseling G, de Jager W, Hellwig VA, Snepvangers FJ, Schols AM.

Am J Clin Nutr. 2011 Dec;94(6):1504-12. doi: 10.3945/ajcn.111.023911. Epub 2011 Nov 9.

18.

Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.

Lindberg A, Larsson LG, Rönmark E, Jonsson AC, Larsson K, Lundbäck B.

COPD. 2007 Mar;4(1):5-13.

PMID:
17364672
20.

Exercise-induced systemic effects in muscle-wasted patients with COPD.

Van Helvoort HA, Heijdra YF, Thijs HM, Viña J, Wanten GJ, Dekhuijzen PN.

Med Sci Sports Exerc. 2006 Sep;38(9):1543-52.

PMID:
16960513

Supplemental Content

Support Center